CTMX
NASDAQ
$3.52
CytomX Therapeutics Inc (CTMX)
CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company in the United States. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $12.50 (+255.11%)
Market Cap
$652M
PEG Ratio
0.76
Forward P/E
14.20
P/E Ratio
24.82
Price Chart
Valuation
Market Cap$652M
P/E24.82
Forward P/E14.20
PEG0.76
P/S22.42
P/B2.48
Profitability
Total Revenue (TTM)$68M
Gross Profit (TTM)$36M
EBITDA-$39M
Profit Margin-166.4%
Operating Margin-191.8%
EPS$0.15
Financial Health
Free Cash Flow Yield-12.33%
Growth & Risk
Revenue 5Y CAGR-7.54%
Beta (5Y)2.01
Sharpe Ratio0.82